Audio Conference: Evidence Based Medicine in Pharmaceuticals

February 3rd, 2009

90 Minute Audio Conference

2PM Eastern Standard Time

 

Speaker:

Ranjani Manjunath
US Health Outcomes Neurosciences
GlaxoSmithKline

 

Evidence Based Medicine in Pharmaceuticals
Evidence Based medicine is defined as the utilization of evidence to improve medical practice by assessing risks and benefits of treatments. As therapy prices continue to rise, the need for health economic, outcomes, and quality of life data will increasingly play a role in payer and government decisions on coverage. Pharmaceutical companies need to be able to develop and provide products that deliver better patient outcomes and that are valued by payers and providers. In order to do this, they must use one of the several methods to determine the economic value of their products. This audio conference will cover:

• What is evidence based medicine and how does it impact clinical practices?
  
• Various methods used by pharmaceutical companies to determine the economic value of their therapies
  
  • Clinical studies to assess QOL
    
  • Patient registry
    
  • Retrospective study
    
• What is the future for evidence-based medicine in the pharmaceutical industry?
  

About the Speaker:

Ranjani Manjunath, MSPH is a manager in the Global Health Outcomes Department at GlaxoSmithKline. She received her training in Health Policy and Administration at the University of North Carolina at Chapel Hill, where she specialized in pharmacoeconomics and outcomes research.

 

After receiving her Master’s, she joined the Health Economics department at RTI Health Solutions and supported outcomes studies in many therapeutic areas for 4 years. Since 2004, Ranjani has worked at GSK, designing and conducting health outcomes studies across a broad range of therapeutic areas including respiratory, neurology, and psychiatry.

 

Her work has encompassed the selection and use of established instruments to measure health-related quality of life, patient satisfaction, and adherence; new instrument development; and the determination and application of minimum important differences for PRO instruments.

 

Ranjani has presented her work at various clinical and health outcomes conferences. She is also currently guest lecturing for the School of Pharmacy at Campbell University.

 

To Register Click Here

 

For multiple registrations please contact:
Paul Hernandez, Marketing Manager
Phernandez@Q1productions.com
312-602-9684